Answers are grounded in this paper and cite their sources.
Case reports demonstrate tumor response to pembrolizumab in metaplastic breast carcinoma, suggesting potential benefits.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ishikawa et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: